The Science Journal of the American Association for Respiratory
Care  2010 OPEN FORUM Abstracts   Crystal Robertson, Kimberly
Bauser, Carl Haas; University of Michigan Hospital, Monroe, MI
BACKGROUND: We use HFOV for refractory hypoxemia and applied it
to patients with H1N1 Influenza ARDS. STUDY OBJECTIVE: To
compare treatment and outcome of the H1N1 patients with non-H1N1
HFOV patients. STUDY DESIGN: Retrospective review of the
following from a HFOV database: gender, ARDS trigger, BMI,
mortality, use of iNO and ECMO, incidence of airleaks, and
duration of ventilation. OI, and PaCO2 were recorded at
baseline, and at hour 1, 12, 24, 48 of HFOV. RESULTS: 28 H1N1
(H) patients were compared with 28 non-H1N1 (NH) patients during
a similar period. There were 68% vs 64% males, with a mean age
of 40 + 12 vs 43 + 20 years and a BMI of 40 + 10 vs 32 + 10 for
H and NH respectively. ARDS triggers for NH included pneumonia
(43%) and sepsis (39%), while all H was pneumonia. Air leaks
were present at baseline in 7% (H) and